Boutique MedTech CRO gains access to unified eClinical platform with wholesale pricing, training, and joint marketing ...

Worldwide Clinical Trials is expanding its horizons with the acquisition of Catalyst Clinical Research, a specialist oncology ...

Services Market OverviewThe global contract research organization services market is poised to register steady growth at an ...

Clinical trial delays impact outcomes. Learn why CROs need a supply chain partner they can trust to reduce delays and help ...

Cronos (CRO) saw whale spikes and leadership changes this month. Trading around $0.09 as January ends, investors wonder if it can reach $1, a 10x gain.

Forbes contributors publish independent expert analyses and insights. Karen Walker focuses on strategies for leaders in hyper-growth. I met with Lauren Goldstein, Chief Revenue Officer (CRO) for ...

Crypto.com (CRO) is on a breakout this morning. On Monday, Cronos (CRO) tumbled by 11.94%. Following a 10.59% slide on Sunday, CRO ended the day at $0.2759. The sell-off came in response to Crypto.com ...

EQT Private Equity and the private equity business of Goldman Sachs Asset Management announced the acquisition agreement Friday. The deal comes four years after Parexel was purchased by Pamplona ...

Key takeaways Cronos (CRO) is the native cryptocurrency token of the Cronos chain, a decentralized, open-source blockchain developed by the Crypto.com payment, trading, and financial services company.

Short CRO traders were paying as much as 3% premium to long traders on Nov. 14, reflecting extreme bearishness in its futures market. Crypto.com’s native token Cronos (CRO) is showing restraint on Nov ...